China NMPA Inspection - National Medical Products Administration - December 22, 2021

On December 22, 2021, the Sichuan Provincial Drug Administration issued a notice to all city and prefecture market supervision administrations, forwarding Announcement No. 100 of 2021 from the National Medical Products Administration (NMPA). This NMPA announcement reported the detection of prohibited ingredients in two batches of cosmetics. While specific companies are not individually named in this directive, the focus is on any "businesses operating in this area" found to be selling the implicated products. The regulatory framework is established by the NMPA, with enforcement responsibilities cascaded to provincial and local drug administrations. The main violation involves non-compliance with cosmetic safety regulations due to the presence of unauthorized substances. Required actions for local administrations include strengthening inspections of relevant businesses, immediately ordering the cessation of sales for the identified problematic cosmetics, thoroughly investigating the businesses' purchase and inspection records, and severely punishing any illegal activities. Cases deemed to be criminal in nature must be promptly transferred to public security organs for further action. This directive emphasizes ensuring public safety and regulatory adherence within the cosmetics market.